Gene · 6358
Papers2,754
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,754
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Curcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases. | Inflammopharmacology | 2023 | 36997729 | PubTator, text mining | PubMed |
| Structural insights into plasmalemma vesicle-associated protein (PLVAP): Implications for vascular endothelial diaphragms and fenestrae. | Proc Natl Acad Sci U S A | 2023 | 36996108 | PubTator, text mining | PubMed |
| Different roles of protein biomarkers predicting eGFR trajectories in people with chronic kidney disease and diabetes mellitus: a nationwide retrospective cohort study. | Cardiovasc Diabetol | 2023 | 36991445 | PubTator, text mining | PubMed |
| Predicting the Development of Renal Replacement Therapy Indications by Combining the Furosemide Stress Test and Chemokine (C-C Motif) Ligand 14 in a Cohort of Postsurgical Patients. | Crit Care Med | 2023 | 36988335 | PubTator, text mining | PubMed |
| The Mac Is Back: The Role of Macrophages in Human Healthy and Complicated Pregnancies. | Int J Mol Sci | 2023 | 36982375 | PubTator, text mining | PubMed |
| Frequency of Peripheral CD8+ T Cells Expressing Chemo-Attractant Receptors CCR1, 4 and 5 Increases in NPC Patients with EBV Clearance upon Radiotherapy. | Cancers (Basel) | 2023 | 36980772 | PubTator, text mining | PubMed |
| Addressing Natural Killer Cell Dysfunction and Plasticity in Cell-Based Cancer Therapeutics. | Cancers (Basel) | 2023 | 36980629 | PubTator, text mining | PubMed |
| Phase I Trial of [99mTc]Tc-maSSS-PEG2-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors. | Cancers (Basel) | 2023 | 36980517 | PubTator, text mining | PubMed |
| Recent Emerging Immunological Treatments for Primary Brain Tumors: Focus on Chemokine-Targeting Immunotherapies. | Cells | 2023 | 36980182 | PubTator, text mining | PubMed |
| Genomic Analysis Reveals New Integrative Conjugal Elements and Transposons in GBS Conferring Antimicrobial Resistance. | Antibiotics (Basel) | 2023 | 36978411 | PubTator, text mining | PubMed |
Development and validation of a nomogram for predicting in-hospital mortality of elderly patients with persistent sepsis-associated acute kidney injury in intensive care units: a retrospective cohort study using the MIMIC-IV database. | BMJ Open | 2023 | 36972970 | PubTator, text mining | PubMed |
| Post-injury born oligodendrocytes incorporate into the glial scar and contribute to the inhibition of axon regeneration. | Development | 2023 | 36971369 | PubTator, text mining | PubMed |
| Human cortical spheroids with a high diversity of innately developing brain cell types. | Stem Cell Res Ther | 2023 | 36959625 | PubTator, text mining | PubMed |
| Prognostic Value of En-Block Radical Bowel Resection in Advanced Ovarian Cancer Surgery With HIPEC. | Cancer Control | 2023 | 36958947 | PubTator, text mining | PubMed |
| Transcriptomic atlas and interaction networks of brain cells in mouse CNS demyelination and remyelination. | Cell Rep | 2023 | 36952346 | PubTator, text mining | PubMed |
| Association Between Hamstring Shortness and Asymmetry, Pain Intensity, Disability Index, and Compensatory Lumbar Movement in 60 Patients with Nonspecific Chronic Low Back Pain. | Med Sci Monit | 2023 | 36949625 | PubTator, text mining | PubMed |
| Localized microglia dysregulation impairs central nervous system myelination in development. | Acta Neuropathol Commun | 2023 | 36949514 | PubTator, text mining | PubMed |
| The meiotic LINC complex component KASH5 is an activating adaptor for cytoplasmic dynein. | J Cell Biol | 2023 | 36946995 | PubTator, text mining | PubMed |
| Acute kidney injury in diabetes mellitus: Epidemiology, diagnostic, and therapeutic concepts. | FASEB J | 2023 | 36943403 | PubTator, text mining | PubMed |
| Neuronal guidance genes in health and diseases. | Protein Cell | 2023 | 36942388 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6358/papers?page=23